Cargando…
Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan
End-stage renal disease (ESRD) patients are mostly managed with maintenance hemodialysis (MHD). ESRD patients on MHD also present with many complications, such as anemia, hyperparathyroidism, and hepatitis prevalence. This study depicts the real-world scenario of anemia among MHD and end-stage renal...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940945/ https://www.ncbi.nlm.nih.gov/pubmed/36815007 http://dx.doi.org/10.1155/2023/7418857 |
_version_ | 1784891178589618176 |
---|---|
author | Bukhari, Humera Ahmad, Aneeqa Noorin, Amna Khan, Aimal Mushtaq, Mehwish Naeem, Aamir Iqbal, Muhammad Rashid Naureen, Faiza Shah, Yasar Qayyum, Ahad Munib, Syed Azhar, Amer Ullah, Farman Khan, Faris Farooq Saeed |
author_facet | Bukhari, Humera Ahmad, Aneeqa Noorin, Amna Khan, Aimal Mushtaq, Mehwish Naeem, Aamir Iqbal, Muhammad Rashid Naureen, Faiza Shah, Yasar Qayyum, Ahad Munib, Syed Azhar, Amer Ullah, Farman Khan, Faris Farooq Saeed |
author_sort | Bukhari, Humera |
collection | PubMed |
description | End-stage renal disease (ESRD) patients are mostly managed with maintenance hemodialysis (MHD). ESRD patients on MHD also present with many complications, such as anemia, hyperparathyroidism, and hepatitis prevalence. This study depicts the real-world scenario of anemia among MHD and end-stage renal disease patients in the Pakistani population. A retrospective, multicentric, and real-world data analytical study was conducted at 4 dialysis centers in Pakistan. The study had a sample size of n = 342 patients on maintenance hemodialysis. The data were gathered from the medical records of patients. Data analysis was performed using STATA Version 16. Statistical significance was gauged at a 0.05 level of significance. According to our results, the mean age of the patients was 45 (±15) years. Most of the patients were male (n = 234, 68.4%), whereas 58.1% of the patients were maintained on twice-weekly hemodialysis. The most commonly reported comorbidities were hypertension and diabetes mellitus. The frequency of dialysis (P < 0.01) and comorbidities (P = 0.009) had a significant association with anemia in MHD patients. The majority of the patients had hyperparathyroidism (52%) with anemia. Upon performing binary logistic regression, multivariate analysis displayed a similar odds value for having anemia in patients with every additional month in the duration of hemodialysis (OR 1.01, P = 0.001), the odds of anemic patients having a positive antihepatitis-C antibody (OR 2.22, P = 0.013), and the odds of having anemia in patients in the age category below 45 years (OR 1.93, P = 0.013). In conclusion, the study results depict that every additional month in the duration of hemodialysis, age (<45 years), and positive anti-HCV antibody status, these variables were more likely to have anemia in our study MHD patients. While in our final multivariate model, no statistically significant association was observed between hyperparathyroidism and anemia. |
format | Online Article Text |
id | pubmed-9940945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-99409452023-02-21 Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan Bukhari, Humera Ahmad, Aneeqa Noorin, Amna Khan, Aimal Mushtaq, Mehwish Naeem, Aamir Iqbal, Muhammad Rashid Naureen, Faiza Shah, Yasar Qayyum, Ahad Munib, Syed Azhar, Amer Ullah, Farman Khan, Faris Farooq Saeed Int J Clin Pract Research Article End-stage renal disease (ESRD) patients are mostly managed with maintenance hemodialysis (MHD). ESRD patients on MHD also present with many complications, such as anemia, hyperparathyroidism, and hepatitis prevalence. This study depicts the real-world scenario of anemia among MHD and end-stage renal disease patients in the Pakistani population. A retrospective, multicentric, and real-world data analytical study was conducted at 4 dialysis centers in Pakistan. The study had a sample size of n = 342 patients on maintenance hemodialysis. The data were gathered from the medical records of patients. Data analysis was performed using STATA Version 16. Statistical significance was gauged at a 0.05 level of significance. According to our results, the mean age of the patients was 45 (±15) years. Most of the patients were male (n = 234, 68.4%), whereas 58.1% of the patients were maintained on twice-weekly hemodialysis. The most commonly reported comorbidities were hypertension and diabetes mellitus. The frequency of dialysis (P < 0.01) and comorbidities (P = 0.009) had a significant association with anemia in MHD patients. The majority of the patients had hyperparathyroidism (52%) with anemia. Upon performing binary logistic regression, multivariate analysis displayed a similar odds value for having anemia in patients with every additional month in the duration of hemodialysis (OR 1.01, P = 0.001), the odds of anemic patients having a positive antihepatitis-C antibody (OR 2.22, P = 0.013), and the odds of having anemia in patients in the age category below 45 years (OR 1.93, P = 0.013). In conclusion, the study results depict that every additional month in the duration of hemodialysis, age (<45 years), and positive anti-HCV antibody status, these variables were more likely to have anemia in our study MHD patients. While in our final multivariate model, no statistically significant association was observed between hyperparathyroidism and anemia. Hindawi 2023-02-13 /pmc/articles/PMC9940945/ /pubmed/36815007 http://dx.doi.org/10.1155/2023/7418857 Text en Copyright © 2023 Humera Bukhari et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bukhari, Humera Ahmad, Aneeqa Noorin, Amna Khan, Aimal Mushtaq, Mehwish Naeem, Aamir Iqbal, Muhammad Rashid Naureen, Faiza Shah, Yasar Qayyum, Ahad Munib, Syed Azhar, Amer Ullah, Farman Khan, Faris Farooq Saeed Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
title | Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
title_full | Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
title_fullStr | Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
title_full_unstemmed | Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
title_short | Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan |
title_sort | association of anemia with parathyroid hormone levels and other factors in patients with end-stage renal disease undergoing hemodialysis: a cross-sectional, real-world data study in pakistan |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940945/ https://www.ncbi.nlm.nih.gov/pubmed/36815007 http://dx.doi.org/10.1155/2023/7418857 |
work_keys_str_mv | AT bukharihumera associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT ahmadaneeqa associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT noorinamna associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT khanaimal associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT mushtaqmehwish associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT naeemaamir associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT iqbalmuhammadrashid associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT naureenfaiza associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT shahyasar associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT qayyumahad associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT munibsyed associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT azharamer associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT ullahfarman associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan AT khanfarisfarooqsaeed associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan |